Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-28

Clinical Trial Update: Chlorhexidine Cordcare for Reduction in Neonatal Mortality and Omphalitis [Phase 3]

View source ↗

Summary

Phase 3 trial update on chlorhexidine cord care to reduce neonatal mortality and omphalitis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine cord care (Chlorhexidine gluconate)

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Neonatal Mortality, Cord Care | Phase 3 | Status: COMPLETED